Protocadherin-1 is a Glucocorticoid-responsive Critical Regulator of Airway Epithelial Barrier Function

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2015 Aug 1

PMID 26227965

Citations 17

Authors

Yutaka Kozu

Yasuhiro Gon

Shuichiro Maruoka

Kuroda Kazumichi

Akiko Sekiyama

Hiroyuki Kishi

Yasuyuki Nomura

Minoru Ikeda

Shu Hashimoto

Affiliations

Soon will be listed here.

Abstract

Background: Impaired epithelial barrier function renders the airway vulnerable to environmental triggers associated with the pathogenesis of bronchial asthma. We investigated the influence of protocadherin-1 (PCDH1), a susceptibility gene for bronchial hyperresponsiveness, on airway epithelial barrier function.

Methods: We applied transepithelial electric resistance and dextran permeability testing to evaluate the barrier function of cultured airway epithelial cells. We studied PCDH1 function by siRNA-mediated knockdown and analyzed nasal or bronchial tissues from 16 patients with chronic rhinosinusitis (CRS) and nine patients with bronchial asthma for PCDH1 expression.

Results: PCDH1 was upregulated with the development of epithelial barrier function in cultured airway epithelial cells. Immunocytochemical analysis revealed that PCDH localized to cell-cell contact sites and colocalized with E-cadherin at the apical site of airway epithelial cells. PCDH1 gene knockdown disrupted both tight and adhesion junctions. Immunohistochemical analysis revealed strong PCDH1 expression in nasal and bronchial epithelial cells; however, expression decreased in inflamed tissues sampled from patients with CRS or bronchial asthma. Dexamethasone (Dex) increased the barrier function of airway epithelial cells and increased PCDH1 expression. PCDH1 gene knockdown eradicated the effect of Dex on barrier function.

Conclusion: These results suggest that PCDH1 is important for airway function as a physical barrier, and its dysfunction is involved in the pathogenesis of allergic airway inflammation. We also suggest that glucocorticoids promotes epithelial barrier integrity by inducing PCDH1.

Citing Articles

A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies.

Rissmann M, Noack D, Spliethof T, Vaes V, Stam R, van Run P PLoS Pathog. 2025; 21(1):e1012875.

PMID: 39841788 PMC: 11774489. DOI: 10.1371/journal.ppat.1012875.

Tezepelumab: patient selection and place in therapy in severe asthma.

Menzella F, Munari S, Corsi L, Tonin S, Cestaro W, Ballarin A J Int Med Res. 2024; 52(4):3000605241246740.

PMID: 38676539 PMC: 11056094. DOI: 10.1177/03000605241246740.

Effect of air pollution on asthma.

Zhou X, Sampath V, Nadeau K Ann Allergy Asthma Immunol. 2024; 132(4):426-432.

PMID: 38253122 PMC: 10990824. DOI: 10.1016/j.anai.2024.01.017.

Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection.

Slough M, Li R, Herbert A, Lasso G, Kuehne A, Monticelli S Nat Commun. 2023; 14(1):4454.

PMID: 37488123 PMC: 10366084. DOI: 10.1038/s41467-023-40126-y.

Non-coding regions of nuclear-DNA-encoded mitochondrial genes and intergenic sequences are targeted by autoantibodies in breast cancer.

Obaidat D, Giordo R, Kleinbrink E, Banisad E, Grossman L, Arshad R Front Genet. 2023; 13:970619.

PMID: 37082114 PMC: 10111166. DOI: 10.3389/fgene.2022.970619.

References

Holgate S . Novel targets of therapy in asthma. Curr Opin Pulm Med. 2008; 15(1):63-71. DOI: 10.1097/MCP.0b013e32831da867. View

Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, Fitzgerald J . Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1):143-78. DOI: 10.1183/09031936.00138707. View

Terakado M, Gon Y, Sekiyama A, Takeshita I, Kozu Y, Matsumoto K . The Rac1/JNK pathway is critical for EGFR-dependent barrier formation in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2010; 300(1):L56-63. DOI: 10.1152/ajplung.00159.2010. View

Meltzer E, Hamilos D . Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc. 2011; 86(5):427-43. PMC: 3084646. DOI: 10.4065/mcp.2010.0392. View

Weiser N, Molenda N, Urbanova K, Bahler M, Pieper U, Oberleithner H . Paracellular permeability of bronchial epithelium is controlled by CFTR. Cell Physiol Biochem. 2011; 28(2):289-96. DOI: 10.1159/000331742. View

Xiao C, Puddicombe S, Field S, Haywood J, Broughton-Head V, Puxeddu I . Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011; 128(3):549-56.e1-12. DOI: 10.1016/j.jaci.2011.05.038. View

Schweitzer K, Hatoum H, Brown M, Gupta M, Justice M, Beteck B . Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol. 2011; 301(6):L836-46. PMC: 3233827. DOI: 10.1152/ajplung.00385.2010. View

Koning H, Sayers I, Stewart C, de Jong D, Ten Hacken N, Postma D . Characterization of protocadherin-1 expression in primary bronchial epithelial cells: association with epithelial cell differentiation. FASEB J. 2011; 26(1):439-48. DOI: 10.1096/fj.11-185207. View

Sekiyama A, Gon Y, Terakado M, Takeshita I, Kozu Y, Maruoka S . Glucocorticoids enhance airway epithelial barrier integrity. Int Immunopharmacol. 2012; 12(2):350-7. DOI: 10.1016/j.intimp.2011.12.006. View

10.

Georas S, Rezaee F . Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014; 134(3):509-20. PMC: 4170838. DOI: 10.1016/j.jaci.2014.05.049. View

11.

Claude P . Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol. 1978; 39(2-3):219-32. DOI: 10.1007/BF01870332. View

12.

Carayol N, Vachier I, Chanez P, Vignola A, Chiappara G . Corticosteroid-induced epithelial shedding in asthma. Am J Respir Crit Care Med. 2002; 166(9):1290-1; author reply 1291. DOI: 10.1164/ajrccm.166.9.267b. View

13.

Koning H, Postma D, Brunekreef B, Duiverman E, Smit H, Thijs C . Protocadherin-1 polymorphisms are associated with eczema in two Dutch birth cohorts. Pediatr Allergy Immunol. 2011; 23(3):270-7. DOI: 10.1111/j.1399-3038.2011.01201.x. View

14.

Takishima T, Hida W, Suzuki S, Sasaki T . Direct graphical recordings of the cumulative dose-response curves of the airway to methacholine in normal, bronchitic and asthmatic subjects. Tohoku J Exp Med. 1981; 135(2):117-37. DOI: 10.1620/tjem.135.117. View

15.

Cockcroft D . Nonallergic airway responsiveness. J Allergy Clin Immunol. 1988; 81(1):111-9. DOI: 10.1016/0091-6749(88)90229-1. View

16.

Cozens A, Yezzi M, Chin L, Simon E, Friend D, Gruenert D . Chloride ion transport in transformed normal and cystic fibrosis epithelial cells. Adv Exp Med Biol. 1991; 290:187-94; discussion 194-6. DOI: 10.1007/978-1-4684-5934-0_19. View

17.

Haws C, Krouse M, Xia Y, Gruenert D, Wine J . CFTR channels in immortalized human airway cells. Am J Physiol. 1992; 263(6 Pt 1):L692-707. DOI: 10.1152/ajplung.1992.263.6.L692. View

18.

Sano K, Tanihara H, Heimark R, Obata S, Davidson M, John T . Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J. 1993; 12(6):2249-56. PMC: 413453. DOI: 10.1002/j.1460-2075.1993.tb05878.x. View

19.

Cozens A, Yezzi M, Kunzelmann K, Ohrui T, Chin L, Eng K . CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1994; 10(1):38-47. DOI: 10.1165/ajrcmb.10.1.7507342. View

20.

Wine J, Finkbeiner W, Haws C, Krouse M, Moon S, Widdicombe J . CFTR and other Cl- channels in human airway cells. Jpn J Physiol. 1994; 44 Suppl 2:S199-205. View